Loading KaiNews…
Coverage of this event
1 publisher · 1 report
Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second Act Barron's Pfizer hikes full-year outlook as newer products grow, taps company veteran as new CFO CNBC Pfizer Raises 2026 Forecast, Extending Big Pharma Windfall Bloomber
Open story via Google NewsReports are grouped by headline and publication time. Different publishers may use the same wire report; grouping does not establish independent confirmation.
Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second Act Barron's Pfizer hikes full-year outlook as newer products grow, taps company veteran as new CFO CNBC Pfizer Raises 2026 Forecast, Extending Big Pharma Windfall Bloomber